APPLIED CLINICAL TRIALS Issue Alert Having trouble viewing this email? Click here
Web Version | View Digital Edition | Subscribe
In our June issue:

FEATURED

 The Future of Clinical Trial Design
Sony Salzman
While the randomized controlled trial will likely always have its place in clinical research, freelance health and medical innovation writer Sony Salzman outlines three new concepts in clinical trial design that though rolled out cautiously at first–and in low-stakes settings–may usher in a reimagined world of drug development.

Master Protocols: De-risking Complexity
Brian Barnes, Rachael Song
Master protocol studies have emerged as a potential avenue to enhance clinical trial design and R&D efficiency. In implementing these studies, authors explore the use of a risk-based model to navigate the inherent changes and adjustments along the journey–and help maintain data integrity throughout.

Optimizing CRAACO Approaches
Hanne Van de Beek
The push toward patient-centric care and expanded healthcare access continues to build interest and activity around the concept of clinical research as a care option (CRAACO). This report discusses the key considerations and strategies required to successfully integrate CRAACO into mainstream healthcare.

NEWS
Eye on Patient Advocacy: Third column in series outlines a three-tiered strategy to long-term relationship building among community physicians.

Washington Report: Jill Wechsler on the expanding foothold for real-world evidence in driving clinical research efforts.

EU Report: Peter O'Donnell details WHO's "Road Map" to balancing R&D investment and fair and affordable drug pricing.

Q&A: Practicing oncologist and director for real-world data (RWD) and analytics company discusses RWD's impact on cancer trials and treatment.

Regulatory: Examining important industry takeaways from FDA's draft guidance on master protocols in cancer R&D.

CLINICAL TRIAL INSIGHTS
Reveling in Record Drug Approvals
Ken Getz
2018's record number of clearances by the FDA points to the emergence of a new R&D operating environment, driven by a changing community of sponsors.
CLOSING THOUGHT
Assessing Success Probability in R&D
Uma Arumugam
Innovation in clinical trial design methodologies are helping to predict the probability of success (POS) in drug development more efficiently and rapidly.
View the digital Issue
image
 
BLOGS
Interactive Voice Tools and AI Reduce Subject Burden
The Risks of KRI in RBM
How Fast is Europe Filling in the Gaps in Its Rare Disease Networks?
WEBCAST
Operational Challenges in Seasonal Infectious Disease Studies
Gain a better understanding of the operational challenges in resourcing and executing seasonal infectious disease trials, and collect key insights into strategies to mitigate these risks.

If you would like to submit an article to Applied Clinical Trials, contact Lisa Henderson, Editorial Director - lhenderson@mmhgroup.com

Applied Clinical Trials is free to qualified subscribers. To subscribe, click here.

Click here to contact the Applied Clinical Trials sales team.
Twitter LinkedIn